Company: AstraZeneca
Posted by CV_Veteran_99 · May 20, 2026
Tags: launch, strategy, rumors
Just saw the news about Baxfendy getting the green light as the first aldosterone synthase inhibitor.
Huge win for the CV team.
Does anyone have the inside scoop on the launch timeline or how they're planning to structure the new expansion? I'm hearing rumors of a pretty aggressive rollout.
Is this going to be a standalone team or are they folding it into the existing CV portfolio?.
0 upvotes · 0 comments